Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Panax notoginseng is a traditional Chinese herb containing ginsenosides Rb1 and Rg1 that improve circulation through vasodilation and anti-inflammatory effects. Clinical studies show it enhances stroke recovery outcomes and lung function in COPD patients.
Origin & History
Panax notoginseng is a perennial herb native to southwestern China, primarily sourced from the roots and rhizomes of the plant (family Araliaceae). It is extracted using water decoction or ethanol extraction methods to isolate active triterpenoid saponins (ginsenosides), which are standardized to 85-95% total saponins in preparations like Xuesaitong.
Research Narrative (Provisional)
A landmark multicenter RCT with 2,970 ischemic stroke patients demonstrated Xuesaitong's superiority over placebo for functional recovery (PMID: 37338907). Meta-analyses covering 20 RCTs in COPD patients (n=1,831) and multiple stroke studies confirm benefits for cardiovascular and neurological outcomes (PMIDs: 38216446, 38898926, 30166105).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Panax notoginseng root contains negligible macronutrients in therapeutic doses (typically 1–3g/day as powder or 200–600mg standardized extract). Key bioactive compounds include saponins (3–8% dry weight) dominated by notoginsenoside R1 (~0.3–1.2% DW), ginsenosides Rg1 (~1–3% DW) and Rb1 (~1–2% DW), and dencichine (β-N-oxalyl-L-α,β-diaminopropionic acid, ~0.1–0.5% DW). Minor saponins include Rd, Re, and Rc. Also contains flavonoids (quercetin, kaempferol glycosides at ~0.1–0.3% DW), polysaccharides (~5–8% DW with immunomodulatory activity), and trace minerals including iron (~15–25 mg/100g), calcium (~80–120 mg/100g), and zinc (~2–4 mg/100g). Bioavailability of ginsenosides is limited orally (Rg1 absolute bioavailability ~18–32% in humans); gut microbiota convert Rb1 into more bioavailable compound K, making microbiome status a key variable. Notoginsenoside R1 is relatively unique to this species versus Panax ginseng.
Reported Mechanism (Provisional)
Panax notoginseng's primary bioactive compounds, ginsenosides Rb1 and Rg1, modulate nitric oxide synthase to promote vasodilation and improve microcirculation. These saponins inhibit platelet aggregation through cyclooxygenase pathways and reduce inflammatory cytokines like TNF-α and IL-6. The herb also activates AMPK signaling pathways to enhance cellular energy metabolism.
Clinical Narrative (Provisional)
A large randomized controlled trial (n=2,970) demonstrated that Panax notoginseng significantly improved stroke recovery, with 89.3% of patients achieving functional independence compared to 82.4% in the placebo group at 3 months. A meta-analysis of 20 RCTs found consistent improvements in lung function for COPD patients, including enhanced FEV1 values and oxygen levels alongside reduced blood viscosity. The evidence base consists primarily of studies conducted in Asian populations with dosages ranging from 3-9 grams daily. While results are promising, more research in diverse populations is needed to confirm universal efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.